| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hanmi Pharmaceutical Co., Ltd. | 20% | $115,375 | 508,710 | Hanmi Pharmaceutical Co., Ltd. | 18 Mar 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$4,414 | 0 | |
| 2024 Q4 | 19,592 | $4,414 | +$4,393 | $0.2268 | 2 |
| 2024 Q3 | 92 | $38 | $0 | $0.4130 | 1 |
| 2024 Q2 | 92 | $70 | -$43,999 | $0.7609 | 1 |
| 2024 Q1 | 26,758 | $44,153 | -$79,200 | $1.66 | 2 |
| 2023 Q4 | 74,758 | $188,234 | $0 | $2.53 | 2 |
| 2023 Q3 | 74,758 | $209,258 | +$59,716 | $2.80 | 2 |
| 2023 Q2 | 53,424 | $247,427 | -$16,350,655 | $4.64 | 2 |
| 2023 Q1 | 20,956,721 | $13,413,311 | -$1,031,559 | $0.6400 | 42 |
| 2022 Q4 | 22,969,085 | $13,319,975 | -$980,629 | $0.5800 | 47 |
| 2022 Q3 | 24,503,339 | $14,583,649 | -$329,515 | $0.5956 | 45 |
| 2022 Q2 | 25,037,246 | $18,630,936 | -$2,733,884 | $0.7421 | 41 |
| 2022 Q1 | 28,520,122 | $38,792,039 | -$3,580,782 | $1.36 | 50 |
| 2021 Q4 | 31,167,593 | $42,354,178 | -$20,836,313 | $1.35 | 56 |
| 2021 Q3 | 39,573,391 | $86,388,477 | -$14,086,783 | $2.18 | 61 |
| 2021 Q2 | 47,224,280 | $156,736,746 | -$38,362,555 | $3.32 | 62 |
| 2021 Q1 | 52,368,071 | $312,921,001 | +$27,258,116 | $5.98 | 70 |
| 2020 Q4 | 48,716,530 | $213,595,767 | -$10,656,459 | $4.38 | 64 |
| 2020 Q3 | 46,405,416 | $278,281,516 | +$62,519,000 | $6.00 | 62 |
| 2020 Q2 | 35,922,961 | $226,532,098 | +$4,418,986 | $6.31 | 56 |
| 2020 Q1 | 34,645,396 | $205,482,679 | +$26,188,137 | $5.94 | 49 |
| 2019 Q4 | 30,723,674 | $174,218,000 | +$81,216,820 | $5.67 | 55 |
| 2019 Q3 | 14,205,904 | $29,576,000 | +$4,633,165 | $2.08 | 30 |
| 2019 Q2 | 11,919,591 | $31,117,000 | +$22,569,720 | $2.61 | 28 |
| 2019 Q1 | 3,293,470 | $6,618,000 | +$430,254 | $2.00 | 20 |
| 2018 Q4 | 3,090,406 | $5,904,000 | +$3,412,187 | $1.91 | 17 |
| 2018 Q3 | 1,070,513 | $2,784,000 | +$883,686 | $2.60 | 14 |
| 2018 Q2 | 844,803 | $3,282,000 | +$1,473,043 | $3.94 | 20 |
| 2018 Q1 | 477,823 | $1,509,000 | +$477,591 | $3.17 | 14 |
| 2017 Q4 | 355,490 | $795,000 | +$420,131 | $2.24 | 13 |
| 2017 Q3 | 168,847 | $250,000 | -$1,100,016 | $1.48 | 9 |
| 2017 Q2 | 1,078,658 | $1,327,000 | -$1,369,552 | $1.24 | 6 |
| 2017 Q1 | 2,425,471 | $2,468,000 | -$371,144 | $1.03 | 9 |
| 2016 Q4 | 2,643,944 | $3,621,000 | -$280,205 | $1.40 | 9 |
| 2016 Q3 | 2,899,922 | $6,532,018 | +$885,320 | $2.25 | 10 |
| 2016 Q2 | 2,504,257 | $6,161,020 | -$322,239 | $2.44 | 10 |
| 2016 Q1 | 2,628,108 | $7,734,020 | -$16,062 | $2.95 | 12 |
| 2015 Q4 | 2,632,501 | $6,764,012 | -$502,487 | $2.53 | 9 |
| 2015 Q3 | 2,751,269 | $11,960,000 | -$702,624 | $4.31 | 12 |
| 2015 Q2 | 2,911,514 | $14,907,000 | -$54,104 | $5.10 | 14 |
| 2015 Q1 | 2,921,962 | $15,775,000 | -$1,285,733 | $5.42 | 13 |
| 2014 Q4 | 3,158,681 | $18,681,000 | +$18,658,021 | $5.92 | 7 |